Living with long QT syndrome types 2 and 3
Part of Heart & circulation clinical trials.
This study looks at how long QT syndrome types 2 and 3 affect your daily life and health. It asks you to wear a smartwatch and answer questions to help researchers understand the challenges you face.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and speak English.
- You have a confirmed genetic diagnosis of long QT syndrome type 2 or 3.
- You have had a QTc interval of 480 milliseconds or longer in the past year.
- You can use an iPhone and Apple Watch for the study.
- You are not currently in another drug or device trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether wearable devices can help monitor Long QT Syndrome, a heart condition. It aims to make tracking your heart easier and more convenient than clinic visits.
This trial tests an investigational drug called THRV-1268 in people with a specific genetic form of long QT syndrome (type 2). The goal is to see if it can safely help control the heart's electrical activity and reduce the risk of dangerous heart rhythms.
This study uses your blood or genetic information to make “iPS cells,” lab-grown cells that can help researchers study inherited heart rhythm problems like LQTS, Brugada syndrome, CPVT, or early repolarization syndrome. It may help improve understanding of why these rhythms happen and guide future treatments.
This study looks at how children with certain genetic heart rhythm problems, like long QT syndrome, respond to exercise. It may help doctors understand how to better manage these conditions.
This study watches for high blood pressure and irregular heartbeats in people with CLL who are starting a type of targeted therapy called a BTK inhibitor (acalabrutinib or zanubrutinib). Researchers will use a smartwatch and blood pressure cuff to monitor your heart health at home.
This trial is a “clinical cohort” study, meaning it follows adults with certain heart rhythm issues to understand them better. Your participation may help researchers learn what to expect and how best to support people over time.
Hear when a new Long QT Syndrome Type 3 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.